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Summary
Aim: To assess the value of the British Thoracic Society (BTS) and the American
College of Chest Physicians (ACCP) guidelines to predict which patients with non-
purulent parapneumonic effusions (PPE) warrant chest tube drainage.ee front matter & 2005
med.2005.06.017
ng author. Tel.: +34 973
ess: jporcelp@yahoo.esMethods: A retrospective chart review was performed on all patients who
underwent thoracentesis because of a PPE over a 10-year period at a Spanish
medical center. Classification of PPE as complicated (CPPE) or uncomplicated (UPPE)
was based on the clinician’s decision to insert a chest tube to resolve the effusion.
Empyema was defined as pus in the pleural space. Data collected included patient
demographics, size of the effusion, and microbiological and pleural fluid chemistries
that might influence the physician’s decision to place a chest tube.
Results: Of the 240 patients with PPE who entered the study, 85 had UPPE, 67 had
CPPE, and 88 had empyema. Individual pleural fluid parameters, namely a pHo7.20,
a glucoseo40mg/dL or o60mg/dL, a LDH41000U/L or a positive culture had a
relatively high specificity (from 78% for LDH to 94% for glucoseo40mg/dL), but low
to moderate sensitivity (from 25% for culture to 73% for LDH) in predicting the need
for chest tube placement in non-purulent PPE. While pleural fluid cultures
performed poorly in discriminating UPPE from CPPE (likelihood ratio positive 1.7),
effusion’s size performed the best (likelihood ratio positive 5.7). BTS and ACCP
guidelines yielded measures of sensitivity (98% and 97%, respectively), and negative
likelihood ratio (0.03 and 0.05, respectively) for identifying a CPPE.Elsevier Ltd. All rights reserved.
705262; fax: +34 973 248754.
(J. Manuel Porcel).
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J. Manuel Porcel et al.934Conclusions: Both guidelines have similar accuracy and perform satisfactorily in
distinguishing CPPE from UPPE, albeit at an admissible cost of needlessly increasing
chest tube drainage.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Pleural effusions often accompany bacterial pneu-
monias. In a large prospective series, pleural
effusion was present in 17% of 1383 immune
competent hospitalized adults with community-
acquired pneumonia, but was more frequently
found at baseline (40%) in patients who failed to
respond early to antimicrobial therapy.1
Urgent thoracentesis is recommended in all
patients with sufficiently large parapneumonic
effusions (PPE), since analysis of pleural fluid
assists patient selection for chest tube drainage.2
Grossly purulent fluid (i.e. empyema) is an unques-
tionable indication for pleural drainage. However,
some non-purulent fluids need to be promptly
evacuated to avoid further progression to an
empyema. The identification of these so-called
complicated PPE (CPPE) represents a particular
challenge to the clinician. Recently, evidence-
based guidelines for when to insert a chest tube
in PPE have been developed by the American
College of Chest Physicians (ACCP),3 and the British
Thoracic Society (BTS).4 Both recommend the use
of chest tubes if some pleural fluid or radiographic
characteristics associated with a poor prognosis are
fulfilled. So far, the operating characteristics of the
BTS and ACCP guidelines for the identification of
CPPE have not been analyzed. In this study, we
applied these recommendations to a retrospective
series of patients stratified by their successful
management with chest tubes (CPPE) or antibiotics
alone (uncomplicated PPE [UPPE]), in order to
determine guidelines’ performance.Patients and methods
Since 1994 we have maintained a database on all
patients who undergo thoracentesis in the Arnau de
Vilanova University Hospital, a 450-bed medical
center in Lleida, Spain. We searched this database
that contains clinical and pleural fluid data for
about 1400 patients, and retrospectively, reviewed
the medical records of those with a diagnosis of PPE
or empyema, between January 1994 and April
2004. Patients with empyema secondary to causes
other than pneumonia, such as surgical procedures,
sub-diaphragmatic pathology, trauma, oesophagealperforation or cirrhosis (spontaneous bacterial
empyema), were excluded. Patients dying within
24 h of presentation were also not considered for
the study. The study protocol was approved by the
local Ethics Committee.
PPE was defined as any pleural effusion asso-
ciated with bacterial pneumonia, lung abscess, or
bronchiectasis. Typical or UPPE described those
effusions that were successfully resolved with
antibiotics alone. CPPE referred to those non-
purulent-appearing effusions that required at least
drainage and eventually further interventions,
whereas empyema described frank pus within the
pleural space.5 Patients were classified into these
three groups, and compared in terms of demo-
graphic, radiographic, microbiological and bio-
chemical pleural fluid data. One of the authors
(JMP) assessed the size of the effusion on a
posteroanterior chest radiograph by visually esti-
mating the area of the hemithorax occupied by
pleural fluid. Pleural effusions were deemed to be
large if they affected half or more of the
hemithorax. The following pleural fluid character-
istics were recorded: bacterial culture, cell counts
and differential, glucose, protein, lactate dehy-
drogenase (LDH), adenosine deaminase (ADA), and
pH. All biochemical measurements were performed
on a selective discrete multichannel analyzer
(Hitachi 717 and 917; Hitachi, Tokyo, Japan) using
standard methodology. Specifically, pleural ADA
activity and pH were assessed with an automated
ultraviolet kinetic test (Roche Diagnostics; Barce-
lona, Spain) and through a blood-gas machine,
respectively. In our hospital, the upper limit the
serum LDH range is 480U/L, whereas a pleural ADA
level of 440U/L in a lymphocytic effusion is
considered the cut-off for the diagnosis of tuber-
culous pleurisy.6
Finally, we evaluated the discriminative power of
the BTS and the ACCP guidelines for the identifica-
tion of CPPE. Specifically, BTS consider a non-
purulent PPE as complicated if any of the following
features in pleural fluid are present: pHo7.2,
LDH41000 IU/L, glucoseo40mg/dL or positive
culture.4 Chest tube drainage of large non-purulent
effusions is also accepted for symptomatic relief if
required. On the other hand, ACCP consensus
stated that a positive culture, a pleural fluid
pHo7.2, a pleural fluid glucoseo60mg/dL (if
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occupies more than half of the hemithorax define a
CPPE (category 3).3 Frank pus is termed empyema
(BTS) or category 4 effusion (ACCP) and always
warrants chest tube placement.
Statistical analysis
Median values with interquartile range (25% and
75%) were calculated for the skewed data. For
between-group comparisons of numerical data and
proportions the Kruskal–Wallis test with post hoc
Mann–Whitney U test (significance level of 0.02),
and w2-test with post hoc adjusted residual analysis
were used, respectively. We calculated measures of
diagnostic accuracy (sensitivity, specificity, like-
lihood ratios [LR], and area under ROC curves
[AUC]) for tests that identify a non-purulent CPPE
either individually or in combination (BTS and ACCP
guidelines). The positive LR was defined as the
true-positive rate (sensitivity) divided by the false-
positive rate (1-specificity), whereas the LR nega-
tive was calculated by dividing the false-negative
rate (1-sensitivity) by the specificity. For a test to
have discriminative properties for identifying the
presence of CPPE, the LR positive needs to be
greater than 1, values between 2 and 5 indicating a
clearly useful test. Likewise, for a test to have
discriminative properties for identifying the ab-
sence of CPPE, the LR negative needs to be less
than 1, and the test can be considered useful if the
LR negative falls between 0.2 and 0.5. The AUC
measured the overall diagnostic accuracy of the
tests, with a value of 0.5 identifying a test without
any discriminative properties and a value of 1.0Table 1 Clinical and pleural fluid data of 240 patients w
Variables UPPE (n ¼ 85) CP
Clinical
Male gender 49 (58)y 56
Age (year) 69 (47–80)z 48
Effusion’s size (12 hemithorax) 8 (12)
y 43
Pleural fluid
Positive culture 12 (14) 16
WBC count, 109/L 1.82 (0.69–3.67) 1.4
Neutrophils (%) 69 (32–85)y 84
Glucose (mg/dL) 115 (90–157)z 68
pH 7.42 (7.36–7.48)z 7.2
LDH (U/L) 503 (305–813)y 150
ADA (U/L) 15 (9–26)y 29
Values given as median (quartiles) or no. (%) when appropriat
Significance level of Kruskal–Wallis or w2-tests.
ySignificantly lower than the respective values in the remainde
zSignificantly higher than the respective values in the remaindidentifying a test with a perfect ability to separate
CPPE from UPPE. P values ofo0.05 were considered
statistically significant. Statistical analysis was
performed using the SPSS 10.0 software (SPSS
Inc., Chicago, IL, USA).Results
A total of 240 patients with PPE were eligible for
the study. Of these, 85 had UPPE, 67 had CPPE, and
88 had empyemas. The mean (7SD) age was 57720
years; 169 (70%) were men, and 71 (30%) were
women. Demographic, radiological and pleural fluid
data for each group are presented in Table 1. As
expected, patients with CPPE or empyema yielded
higher pleural LDH levels and positive cultures, and
lower pH and glucose content than those with
UPPE. In addition, effusions of large size were less
prevalent in this latter group. Eight (10%), 19 (30%),
and 43 (63%) patients with UPPE, CPPE, and
empyema, respectively, had pleural fluid ADA levels
above 40U/L. Ninety-one patients (38%) had
positive pleural fluid cultures. Overall, Streptococ-
cus pneumoniae (18 isolates), Streptococcus vir-
idans (16 isolates), and Staphylococcus aureus (11
isolates) were the predominant recovered patho-
gens in pleural fluid. Of note, 10 of the 12 patients
with culture-positive fluids who were successfully
treated without chest tube thoracostomy, had
effusions that occupied a third or less of the
hemithorax. Likewise, no chest tube was inserted
in two patients with empyema because of small
effusion’s size and satisfactory clinical resolution
with antibiotics alone.ith parapneumonic effusion.
PE (n ¼ 67) Empyema (n ¼ 88) P-value
(84)z 64 (73) 0.02
(37–62)y 59 (40–72) o0.001
(72) 40 (64) o0.001
(25) 63 (72)z o0.001
5 (0.5–5.82) 28.4 (0.5–128.65)z o0.001
(71–91) 93 (84–97)z o0.001
(34–109) 4 (1–33)y o0.001
1 (6.96–7.32) 6.87 (6.58–7.03)y o0.001
7 (510–2950) 10,000 (2272–20,000)z o0.001
(22–42) 66 (21–178)z o0.001
e.
r groups.
er groups.
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Table 2 Diagnostic characteristics of different criteria for identifying non-purulent CPPE.
Criteria N Sensitivity
(%)
Specificity
(%)
Positive LR Negative LR AUC
Effusion’s size (4)
(12 hemithorax)
124 72 (59–84) 87 (79–96) 5.7 (2.9–11.2) 0.32 (0.21–0.49)
Positive culture 147 25 (14–36) 85 (77–94) 1.7 (0.9–3.4) 0.88 (0.74–1.04)
pH p7.20 128 49 (35–63) 91 (83–98) 5.3 (2.5–11.2) 0.56 (0.43–0.74) 0.82 (0.74–0.90)
Glucose p60mg/dL 148 43 (30–56) 92 (85–98) 5.1 (2.4–10.9) 0.62 (0.50–0.78) 0.74 (0.65–0.82)
Glucose p40mg/dL 148 31 (19–43) 94 (88–100) 5.1 (2.0–12.9) 0.74 (0.62–0.87) 0.74 (0.65–0.82)
LDH X1000 U/L 146 73 (61–85) 78 (69–88) 3.4 (2.2–5.2) 0.34 (0.23–0.53) 0.81 (0.74–0.88)
BTS criteria 131 98 (95–100) 56 (43–69) 2.2 (1.7–2.9) 0.03 (0.00–0.19)
ACCP criteria 120 97 (91–100) 68 (55–80) 3.0 (2.1–4.3) 0.05 (0.01–0.20)
Data are presented with 95% CIs in parentheses when appropriate.
J. Manuel Porcel et al.936Sensitivity of individual pleural fluid analytes to
identify non-purulent CPPE ranged from 25% for
cultures to 73% for LDH above 1000U/L (Table 2).
Pleural fluid pH had the highest diagnostic accuracy
as measured by the AUC (0.82), although 95%
confidence interval values overlapped with those
of glucose and LDH. A pleural fluid pHo7.20, a
pleural glucoseo60mg/dL or a large effusion’s size
predicted with a likelihood of more than 5 that the
effusion would not resolve unless drainage was
instituted. ACCP and BTS guidelines, which make
use of tests combination in an ‘‘or’’ rule’’ wherein
the pleural space would be drained if any test is
positive, were associated with sensitivities ranging
from 97% to 98% and specificities varying from 56%
to 68% (P ¼ 0:20) to discriminate non-purulent
CPPE from UPPE.
Finally, 11 of 12 (92%) and 13 of 13 (100%)
patients with culture-positive CPPE met ACCP and
BTS criteria for chest tube drainage other than
microbiology, respectively. Of note, these respec-
tive percentages fell to 62% (5 of 8 patients) and
82% (9 of 11 patients) if only pleural fluid
chemistries would have been considered as a valid
criterion. Conversely, among the 12 culture-posi-
tive UPPE, 5 of 8 (63%) and 7 of 9 (78%) patients
fulfilled the remainder ACCP and BTS criteria for
pleural drainage.Discussion
Clinical evaluation of guidelines is important to
ascertain that they are achieving the desired goals.
Our study shows that decision support to drain the
pleural space in PPE based on the BTS or ACCP
guidelines is more effective than is decision support
based on individual pleural fluid tests. Thus, almost
all patients who had a final diagnosis of CPPE metone or more sets of the BTS or ACCP criteria for
chest tube placement. On the contrary, classical
fluid chemistries and cultures per se lacked
sensitivity in categorizing a PPE as complicated.
In clinical practice, the decision to drain a PPE
depends on multiple factors, namely the gross
appearance of the pleural fluid, the pleural fluid
chemistries and culture, the radiographic size of
the effusion, and the general condition of the
patient. There is no clinical value in measuring
biochemical tests of a purulent effusion, as these
empyemas always require chest tube placement for
resolution. Important components of pleural fluid
analysis to predict the future course of a non-
purulent PPE include pH, glucose, LDH, and Gram
stain with culture. If the pleural fluid pH is above
7.2, the pleural fluid glucose is above 60mg/dL,
the pleural fluid LDH is below 1000U/L, and pleural
fluid culture is negative most authors would
typically consider definitive drainage to be unne-
cessary. A meta-analysis of various studies including
274 patients with PPE found little support for the
use of LDH or glucose, and advocated draining
pleural effusions with a pH less than 7.30 in high-
risk patients and less than 7.22 in low-risk
patients.7 High-risk patients were identified by
the presence of a virulent pathogen as the cause
of pneumonia (e.g. S. aureus, Haemophilus influ-
enzae) and a high risk for a poor outcome if pleural
drainage was delayed (e.g. elderly patients, co-
morbid disease). We found considerable overlap
between the AUC values for pH (AUC ¼ 0.82), LDH
(AUC ¼ 0.81), and glucose (AUC ¼ 0.74), which
indicates that no single test seems superior to
others in identifying those PPE that need drainage.
In general, individual pleural variables had rela-
tively high specificity and positive LR to identify
CPPE, ranging from 78% for LDH to 94% for
glucoseo40mg/dL, and from 3.4 for LDH to 5.7
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sensitivities varied from only 25% for a positive
culture to 73% for a fluid LDH41000U/L. We should
stress the disappointing discriminative properties
of pleural fluid cultures (LR positive 1.7, and LR
negative 0.88). In addition, they did not provide
additional information in CPPE beyond that af-
forded by the combined biochemical and radiolo-
gical criteria.
In our study, BTS and ACCP guidelines provided an
advantage of a high sensitivity—albeit at the cost
of a lower specificity—by virtue of having multiple
test components. This strategy supports the clin-
ician’s goal of erring on the side of not overlooking
patients with CPPE because the delayed insertion
of a necessary chest tube may increase morbidity.
Overall, BTS and ACCP guidelines had good operat-
ing characteristics indexes, as reflected by their
useful LR positive (2.2 and 3.0, respectively) and
their excellent LR negative (0.03 and 0.05, respec-
tively). The inclusion of the effusion’s size among
the BTS and ACCP criteria contributed significantly
to their diagnostic accuracy, incrementing the
respective sensitivities by 13% (from 85% to 98%,
P ¼ 0:005) and 34% (from 63% to 97%, Po0:001).
Previously, a few reports have noticed that some
patients with PPE and poor prognostic variables in
pleural fluid can be cured with antibiotics alone.
For example, in a retrospective study of 62 patients
with PPE, 26 non-purulent CPPE defined as pleural
fluid with a pH less than 7.20 or a positive Gram
stain or culture were identified.8 Thirteen of the 16
CPPE initially treated with antibiotics alone cured
uneventfully. Other retrospective analysis of 91
patients with PPE found that patients who had a
pleural fluid pH below 7.00 and/or a pleural fluid
glucose below 40mg/dL were more than three
times as likely to need tube thoracostomy than
those who did not meet these criteria (56% vs. 15%,
Po0:005).9
Several limitations of our study are worth noting.
First, we use the clinician’s final decision to insert a
chest tube as the gold standard in our analyses.
Admittedly, no gold standard exists to establish the
benchmark categorization of PPE into complicated
and uncomplicated, and thus clinical judgment may
misclassify numerous patients.10 Second, it is a
retrospective study on the proper drainage of a
PPE. However, no well-designed prospective clin-
ical studies have addressed this point, nor do such
studies seem likely to, given the ethical imperativeto intervene (i.e., to place a chest tube) if less than
optimal care is observed, and the small number of
cases available from a single institution. Finally, we
did evaluate neither Gram stains nor pleural
locutations or thickened parietal pleural on con-
trast-CT, which were also considered by the ACCP
expert panel as factors associated with a poor
prognosis. Nevertheless, we think that influence of
these data on the overall guidelines’ operating
characteristics should be minimal given the high
sensitivity figures obtained.
To conclude, this study supports further the
evidence already available and published through
the BTS or ACCP guidelines. These recommenda-
tions are useful in predicting the need for chest
tube drainage in non-purulent PPE by virtue of their
high sensitivity. The primary problem with BTS/
ACCP guidelines is that they label some patients
with UPPE as having CPPE, leading to some
unnecessary chest tube placements, a misclassifi-
cation cost which is acceptable from a clinical
standpoint.References
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